Document Detail

{blacktriangledown}Tapentadol (Palexia) for moderate to severe acute pain.
MedLine Citation:
PMID:  22419754     Owner:  NLM     Status:  In-Data-Review    
▾Tapentadol (Palexia - Grünenthal) is a recently introduced strong analgesic with µ-agonistic opioid and additional noradrenaline reuptake inhibition properties. The summary of product characteristics (SPC) states that it is indicated for the relief of moderate to severe acute pain in adults, which can be adequately managed only with opioid analgesics.1 Here we review the place of tapentadol in the treatment of patients with moderate to severe acute pain.
Related Documents :
22571284 - Total knee replacement plus physical and medical therapy or treatment with physical and...
22927064 - Sham surgery controls in parkinson's disease clinical trials: views of participants.
23104514 - Surgery versus conservative care for neck pain: a systematic review.
25019294 - Withdrawn: dipyrone for acute primary headaches.
24731154 - Heart rate and perceived muscle pain responses to a functional walking test in mcardle ...
22280484 - Early intervention for adolescents with patellofemoral pain syndrome--a pragmatic clust...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug and therapeutics bulletin     Volume:  50     ISSN:  1755-5248     ISO Abbreviation:  Drug Ther Bull     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0112037     Medline TA:  Drug Ther Bull     Country:  England    
Other Details:
Languages:  eng     Pagination:  30-3     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneo...
Next Document:  Topical therapy for scalp psoriasis in adults.